Human germ cell tumors are developmental cancers: impact of epigenetics on pathobiology and clinic

J Lobo, AJM Gillis, C Jerónimo, R Henrique… - International journal of …, 2019 - mdpi.com
Current (high throughput omics-based) data support the model that human (malignant) germ
cell tumors are not initiated by somatic mutations, but, instead through a defined locked …

Radiomics allows for detection of benign and malignant histopathology in patients with metastatic testicular germ cell tumors prior to post-chemotherapy …

B Baessler, T Nestler, D Pinto dos Santos… - European …, 2020 - Springer
Objectives To evaluate whether a computed tomography (CT) radiomics–based machine
learning classifier can predict histopathology of lymph nodes (LNs) after post-chemotherapy …

Liquid biopsies in the clinical management of germ cell tumor patients: state-of-the-art and future directions

J Lobo, R Leão, C Jerónimo, R Henrique - International Journal of …, 2021 - mdpi.com
Liquid biopsies constitute a minimally invasive means of managing cancer patients,
entailing early diagnosis, follow-up and prediction of response to therapy. Their use in the …

An exploration of testicular cancer survivors' experience of ejaculatory dysfunction following retroperitoneal lymph node dissection—a sub-study of the PREPARE …

C Conduit, AD Hutchinson, M Leonard… - Journal of Cancer …, 2023 - Springer
Purpose Ejaculatory dysfunction secondary to retrograde ejaculation or anejaculation is a
complication of retroperitoneal lymph node dissection (RPLND) for survivors of testicular …

[HTML][HTML] Canadian Urological Association consensus guideline: Management of testicular germ cell cancer

RJ Hamilton, C Canil, NS Shrem… - Canadian Urological …, 2022 - ncbi.nlm.nih.gov
Methods A multidisciplinary group of Canadian testicular cancer experts (nine medical
oncologists, five uro-oncologists, two radiation oncologists, one genitourinary pathologist …

[HTML][HTML] The combination of microRNA-371a-3p and 375-5p can distinguish viable germ cell tumor and teratoma from necrosis in postchemotherapy retroperitoneal …

L Kremer, M von Brandenstein… - Translational …, 2021 - ncbi.nlm.nih.gov
Background To identify a combination of microRNAs (miRNA) to differentiate between viable
tumor (V) or teratoma (T) and necrosis/fibrosis (N) in pcRPLND specimens of metastatic …

[HTML][HTML] Outcomes of postchemotherapy retroperitoneal lymph node dissection from a high-volume UK centre compared with a national data set

AK Pearce, D Manson-Bahr, A Reid, R Huddart… - European Urology Open …, 2021 - Elsevier
Background Retroperitoneal lymph node dissection (RPLND) is essential for the treatment of
metastatic germ cell tumours of the testis. Recommendations on the referral and …

Radiomics and clinicopathological characteristics for predicting lymph node metastasis in testicular cancer

CS Lisson, S Manoj, D Wolf, CG Lisson, SA Schmidt… - Cancers, 2023 - mdpi.com
Simple Summary Testicular germ cell tumours (TGCTs) are the most common type of solid
cancer in men under the age of 40. Of metastases from TGCTs, 95% involve the ipsilateral …

Serum levels of MicroRNA-371a-3p (M371) can predict absence or presence of vital disease in residual masses after chemotherapy of metastatic seminoma

KP Dieckmann, M Klemke, F Grobelny, A Radtke… - Frontiers in …, 2022 - frontiersin.org
Background Radiological evaluation of postchemotherapy residual masses of metastatic
seminoma is characterized by poor diagnostic accuracy. Serum levels of microRNA-371a-3p …

Testicular cancer with small metastatic burden: optimal approach in 2024

KL Yuen, K Pandit, D Puri… - Current Opinion in …, 2024 - journals.lww.com
Advances in risk stratification and therapy enable personalized de-escalation approaches
for oligometastatic testicular cancer, optimizing survivorship. Upfront RPLND, reassessing …